lipotropic injections with tirzepatide 10 — WEEKLY Lipo C and Tirzepatide: Safety
Description
doi: 10.1016/j.jacc.2022.11.005 2 MarxNHusainMLehrkeMVermaSSattarN
Mounjaro is a dual GIP/GLP1 receptor agonist, while Ozempic is a GLP1 receptor agonist, which partly explains differences in their effects
As a result, quitting smoking can lead to weight gain
Medication interactions and blood pressure changes should also be considered
The interactions between GLP-1/GIP receptor agonists and alcohol are not always well understood, and the information available online is often vague, contradictory, or written for a US audience without reference to NHS guidance
